Salem Investment Counselors’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.69M Sell
9,605
-272
-3% -$71.5K 0.07% 152
2026
Q1
$2.64M Sell
9,877
-100
-1% -$27.1K 0.08% 140
2025
Q4
$2.5M Buy
9,977
+684
+7% +$182K 0.07% 140
2025
Q3
$2.67M Buy
9,293
+50
+0.5% +$13.4K 0.08% 135
2025
Q2
$2.43M Sell
9,243
-11
-0.1% -$2.68K 0.08% 140
2025
Q1
$2.15M Buy
9,254
+11
+0.1% +$2.67K 0.08% 138
2024
Q4
$2.12M Hold
9,243
0.07% 145
2024
Q3
$2.07M Hold
9,243
0.06% 151
2024
Q2
$1.88M Hold
9,243
0.06% 151
2024
Q1
$2.02M Hold
9,243
0.07% 143
2023
Q4
$2.1M Buy
9,243
+6,186
+202% +$1.3M 0.07% 130
2023
Q3
$615K Sell
3,057
-106
-3% -$22.4K 0.02% 215
2023
Q2
$656K Buy
3,163
+250
+9% +$48.5K 0.02% 209
2023
Q1
$574K Hold
2,913
0.02% 229
2022
Q4
$589K Hold
2,913
0.03% 230
2022
Q3
$513K Hold
2,913
0.02% 229
2022
Q2
$587K Buy
2,913
+118
+4% +$25.2K 0.03% 227
2022
Q1
$633K Sell
2,795
-192
-6% -$45.2K 0.02% 231
2021
Q4
$806K Buy
2,987
+74
+3% +$18.3K 0.03% 216
2021
Q3
$704K Buy
2,913
+185
+7% +$46.6K 0.04% 204
2021
Q2
$647K Sell
2,728
-162
-6% -$36.9K 0.04% 211
2021
Q1
$633K Buy
2,890
+259
+10% +$52K 0.04% 191
2020
Q4
$460K Hold
2,631
0.03% 201
2020
Q3
$425K Hold
2,631
0.03% 191
2020
Q2
$375K Hold
2,631
0.03% 196
2020
Q1
$286K Hold
2,631
0.03% 202
2019
Q4
$382K Buy
2,631
+652
+33% +$94.1K 0.03% 206
2019
Q3
$286K Hold
1,979
0.03% 218
2019
Q2
$294K Sell
1,979
-9,079
-82% -$1.27M 0.03% 227
2019
Q1
$1.65M Buy
11,058
+815
+8% +$100K 0.17% 101
2018
Q4
$1.11M Sell
10,243
-815
-7% -$109K 0.14% 104
2018
Q3
$1.65M Buy
11,058
+815
+8% +$124K 0.17% 101
2018
Q2
$1.58M Hold
10,243
0.14% 101
2018
Q1
$1.42M Hold
10,243
0.16% 101
2017
Q4
$1.4M Hold
10,243
0.15% 106
2017
Q3
$1.33M Sell
10,243
-14
-0.1% -$1.87K 0.16% 105
2017
Q2
$1.36M Buy
10,257
+14
+0.1% +$1.71K 0.16% 105
2017
Q1
$1.27M Hold
10,243
0.14% 124
2016
Q4
$1.13M Hold
10,243
0.13% 122
2016
Q3
$12.1K Hold
10,243
0.16% 111
2016
Q2
$1.15M Hold
10,243
0.14% 126
2016
Q1
$1.03M Hold
10,243
0.13% 132
2015
Q4
$1.09M Hold
10,243
0.14% 124
2015
Q3
$946K Hold
10,243
0.12% 136
2015
Q2
$1.07M Buy
10,243
+931
+10% +$96.9K 0.13% 133
2015
Q1
$1.01M Buy
9,312
+116
+1% +$11.9K 0.12% 142
2014
Q4
$852K Hold
9,196
0.1% 150
2014
Q3
$804K Hold
9,196
0.1% 157
2014
Q2
$809K Hold
9,196
0.1% 154
2014
Q1
$776K Buy
+9,196
New +$733K 0.1% 159

Other funds holding LH

Salem Investment Counselors's LH Position: Q2 2026 in Review

Salem Investment Counselors reduced its Labcorp (LH) stake by 2.8% in Q2 2026, selling an estimated $71.5K and leaving 9,605 shares worth $2.69M. The position accounts for 0.07% of the portfolio, ranked #152.

Salem Investment Counselors first reported a position in LH in Q1 2014 and has held it in 50 quarters since. 325 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Salem Investment Counselors held 9,605 shares of Labcorp worth $2.69M as of Q2 2026.
  • Salem Investment Counselors sold 272 Labcorp shares in Q2 2026, an estimated $71.5K.
  • Labcorp made up 0.07% of Salem Investment Counselors's portfolio in Q2 2026, its #152 holding.
  • Salem Investment Counselors first reported a position in Labcorp in Q1 2014 and has held it in 50 quarters since.
  • 325 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Salem Investment Counselors's 13F filing for Q2 2026, filed 14 Jul 2026.